-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
5-(Di-tert-butylphosphino)-1',3',5'-triphenyl-1H-[1,4']bipyrazole, also known as BNY-27885A, is a synthetic organic compound that has been studied for its potential use as a pharmaceutical drug.
The compound is a member of a class of molecules known as pyrazoles, which are aromatic compounds with a six-membered ring composed of carbon and nitrogen atoms.
The production process for BNY-27885A involves several steps, starting with the synthesis of the individual components that make up the molecule.
The first step in the synthesis of BNY-27885A is the preparation of the phosphine precursor, which is a compound that will be used in the formation of the final product.
This is typically done by reacting a phosphorus halide, such as phosphorus trichloride, with a metal hydride, such as sodium hydride.
Once the phosphine precursor has been synthesized, it is then used in the formation of the bipyrazole core of the molecule.
This is typically done by reacting the phosphine precursor with a nitrogen-containing compound, such as ammonia, in the presence of a Lewis acid catalyst, such as aluminum chloride.
After the bipyrazole core has been synthesized, the final step in the production process is the addition of the triphenyl ring to the molecule.
This is typically done by reacting the bipyrazole core with a triphenyl phosphine precursor in the presence of a metal catalyst, such as zinc chloride.
Once the production process is complete, the resulting BNY-27885A can be purified and isolated from the reaction mixture using standard chromatography techniques.
The final product can then be used for further study and evaluation as a potential pharmaceutical drug.
Overall, the production process for BNY-27885A is a multistep synthesis that involves the synthesis of the phosphine precursor, the bipyrazole core, and the triphenyl ring.
The synthesis can be carried out using a variety of chemical reactions and catalysts, and the resulting product can be purified and isolated for further study and evaluation.
